The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Teva Pharmaceutical Industries Limited (TEVA) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.02, or 0.22%, to $9.12. The Teva Pharmaceutical Industries Limited has recorded 123,693 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Teva Shares Progress Toward Access to Medicines and Environmental Commitments, Meeting and Exceeding Several ESG Targets Ahead of Schedule.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
The company is listed on the NYSE and operates within the Drug Manufacturers – Specialty & Generic industry segment. The current market capitalization of Teva Pharmaceutical Industries Limited is $10.20B. A total of 8.33 million shares were traded on the day, compared to an average of 8.70M shares.
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, TEVA has seen 0 BUY and 2 SELL insider trades, representing the acquisition of 0 and the disposition of 77,421 shares. Over the last 12 months, there were 0 BUYs and 2 SELLs from insiders. Insiders purchased 0 shares during that period but sold 77,421.
In the most recent transaction, Dethlefs Sven sold 58,066 shares of TEVA for 9.43 per share on Mar 07. After the transaction, the EVP, North America Commercial now owns 165,381 company shares. In a previous transaction on Mar 07, Daniell Richard sold 54,007 shares at 9.43 per share. TEVA shares that Exec. VP, European Commercial owns now total 69,770.
Among the insiders who sold shares, Stark David Matthew disposed of 49,475 shares on Mar 07 at a per-share price of $9.43. This resulted in the Exec. VP Chief Legal Officer holding 2,974 shares of TEVA after the transaction. In another insider transaction, Drape Eric sold 4,699 shares at $9.43 per share on Mar 07. Company shares held by the Executive VP Global Operations now total 173,262.
The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. TEVA’s most recent ex-dividend date was 11/27/2017 when it declared a $0.0850 quarterly dividend that was paid in cash on 12/12/2017. Previously, the company paid the dividend on 9/14/2017 with an ex-dividend date of 8/25/2017. The TEVA stock dividend was $0.0850 per share in cash.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for TEVA in the last 3 months, the mean price target is $10.19 with high estimates of $14.00 and low estimates of $7.00. In terms of 52-week highs and lows, TEVA has a high of $11.44 and a low of $6.78.
As of this writing, TEVA has an earnings estimate of $0.56 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of $0.57 per share and a lower estimate of $0.54. The company reported an EPS of $0.59 in the last quarter, which was -4.80% lower than expectations of $0.62.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. TEVA’s latest balance sheet shows that the firm has $2.17B in Cash & Short Term Investments as of fiscal 2021. There were $23.46B in debt and $11.03B in liabilities at the time. Its Book Value Per Share was $7.10, while its Total Shareholder’s Equity was $11.24B.
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TEVA is Buy with a score of 2.50.